Skip to content
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Clearmind Medicine Featured in “Psychedelics Tonight,” Streaming on ALTRD.TV

Clearmind Medicine Featured in “Psychedelics Tonight,” Streaming on ALTRD.TV

  • Post published:October 11, 2022
  • Post category:Press Release
Read more about the article Clearmind Announces Notice of Proposed Stock Consolidation

Clearmind Announces Notice of Proposed Stock Consolidation

  • Post published:September 26, 2022
  • Post category:Press Release
Read more about the article Clearmind Applies for Patent to Treat Obesity and Metabolic Syndrome

Clearmind Applies for Patent to Treat Obesity and Metabolic Syndrome

  • Post published:September 23, 2022
  • Post category:Press Release
Read more about the article Clearmind Medicine Announces Share-Based Payment for one of the Company’s Consultants

Clearmind Medicine Announces Share-Based Payment for one of the Company’s Consultants

  • Post published:September 18, 2022
  • Post category:Press Release
Read more about the article Clearmind Medicine Announces Additional Positive Pre-Clinical Results for its Cocaine Addiction Treatment

Clearmind Medicine Announces Additional Positive Pre-Clinical Results for its Cocaine Addiction Treatment

  • Post published:August 24, 2022
  • Post category:Press Release
Read more about the article Yale’s Department of Psychiatry Chair to Join Clearmind Medicine

Yale’s Department of Psychiatry Chair to Join Clearmind Medicine

  • Post published:June 21, 2022
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More